Literature DB >> 8006578

Oral administration of lipopolysaccharides activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induces autoimmune symptoms in an autoantibody transgenic mouse.

M Murakami1, T Tsubata, R Shinkura, S Nisitani, M Okamoto, H Yoshioka, T Usui, S Miyawaki, T Honjo.   

Abstract

About a half of the antierythrocyte autoantibody transgenic (autoAb Tg) mice, in which almost all B cells are detected in the spleen, lymph nodes, and Peyer's patches, but not in the peritoneal cavity, suffer from autoimmune hemolytic anemia. The occurrence of this disease is strongly linked to production of autoAb by activated peritoneal B-1 cells in the Tg mice. In this study, we have shown that oral administration of lipopolysaccharides (LPS) activated B-1 cells in the lamina propria of the gut as well as the peritoneal cavity in the healthy Tg mice and induced the autoimmune symptoms in all the Tg mice. The activation of peritoneal and lamina propria B-1 cells by enteric LPS is found not only in the anti-RBC autoAb Tg mice and normal mice but also in the aly mice which congenitally lack lymph nodes and Peyer's patches. These results suggest that B-1 cells in the two locations may form a common pool independent of Peyer's patches and lymph nodes, and can be activated by enteric thymus-independent antigens or polyclonal activators such as LPS. The induction of autoimmune hemolytic anemia in the Tg mice by enteric LPS through the activation of B-1 cells in the lamina propria of gut and in the peritoneal cavity suggests that B-1 cells and bacterial infection may play a pathogenic role in the onset of autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8006578      PMCID: PMC2191544          DOI: 10.1084/jem.180.1.111

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

1.  Removal of endogenous peroxidase activity from cryostat sections for immunoperoxidase visualisation of monoclonal antibodies.

Authors:  J Kelly; C A Whelan; D G Weir; C Feighery
Journal:  J Immunol Methods       Date:  1987-01-26       Impact factor: 2.303

2.  The Ly-1 B cell lineage.

Authors:  L A Herzenberg; A M Stall; P A Lalor; C Sidman; W A Moore; D R Parks; L A Herzenberg
Journal:  Immunol Rev       Date:  1986-10       Impact factor: 12.988

3.  Molecular mimicry and autoimmune disease.

Authors:  M B Oldstone
Journal:  Cell       Date:  1987-09-11       Impact factor: 41.582

Review 4.  CBA/N immune defective mice; evidence for the failure of a B cell subpopulation to be expressed.

Authors:  I Scher
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

Review 5.  Immunoglobulin genes.

Authors:  T Honjo
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

Review 6.  Autoimmunity--a perspective.

Authors:  H R Smith; A D Steinberg
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

7.  Preparation and purification of lymphocytes from the epithelium and lamina propria of murine small intestine.

Authors:  M D Davies; D M Parrott
Journal:  Gut       Date:  1981-06       Impact factor: 23.059

8.  Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity.

Authors:  J Goverman; A Woods; L Larson; L P Weiner; L Hood; D M Zaller
Journal:  Cell       Date:  1993-02-26       Impact factor: 41.582

9.  Features of systemic lupus erythematosus in mice injected with bacterial lipopolysaccharides: identificantion of circulating DNA and renal localization of DNA-anti-DNA complexes.

Authors:  S Izui; P H Lambert; G J Fournié; H Türler; P A Miescher
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

10.  The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice.

Authors:  K Hayakawa; R R Hardy; D R Parks; L A Herzenberg
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

View more
  51 in total

Review 1.  Maintenance and loss of self-tolerance in B cells.

Authors:  A Iglesias
Journal:  Springer Semin Immunopathol       Date:  2001-12

Review 2.  Isotype-dependent pathogenicity of autoantibodies: analysis in experimental autoimmune hemolytic anemia.

Authors:  S Izui; L Fossati-Jimack; S A da Silveira; T Moll
Journal:  Springer Semin Immunopathol       Date:  2001-12

3.  T cell control of the gut IgA response against commensal bacteria.

Authors:  N A Bos; H Q Jiang; J J Cebra
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

Review 4.  The double life of a B-1 cell: self-reactivity selects for protective effector functions.

Authors:  Nicole Baumgarth
Journal:  Nat Rev Immunol       Date:  2010-12-10       Impact factor: 53.106

5.  B-1 cells in the bone marrow are a significant source of natural IgM.

Authors:  Youn Soo Choi; Jacquelyn A Dieter; Kristina Rothaeusler; Zheng Luo; Nicole Baumgarth
Journal:  Eur J Immunol       Date:  2011-11-28       Impact factor: 5.532

Review 6.  Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion.

Authors:  Nicole Baumgarth; James W Tung; Leonore A Herzenberg
Journal:  Springer Semin Immunopathol       Date:  2005-01-05

7.  Presence of activated B-1 cells in chronic inflamed gingival tissue.

Authors:  M Aramaki; T Nagasawa; T Koseki; I Ishikawa
Journal:  J Clin Immunol       Date:  1998-11       Impact factor: 8.317

8.  Peritoneal lavage reduces lipopolysaccharide-induced elevation of serum TNF-alpha and IL-6 mortality in mice.

Authors:  K Zhao; I Kirman; I Tschepen; R Schwab; M E Weksler
Journal:  Inflammation       Date:  1997-08       Impact factor: 4.092

9.  Natural and induced B-1 cell immunity to infections raises questions of nature versus nurture.

Authors:  Nicole Baumgarth; Elizabeth E Waffarn; Trang T T Nguyen
Journal:  Ann N Y Acad Sci       Date:  2015-06-09       Impact factor: 5.691

10.  Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut.

Authors:  K E Shroff; K Meslin; J J Cebra
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.